CJC-1295 No DAC & Ipamorelin Research: Returning Researcher FAQ

If you stocked these two research compounds before and you are coming back for a repeat order, the molecules have not changed. CJC-1295 No DAC is still a tetrasubstituted GRF (1-29) analog supplied without the drug affinity complex, and Ipamorelin is still a selective pentapeptide growth hormone secretagogue. What changes between orders is the documentation and the supply chain behind the vial — purity method, identity confirmation, salt form, batch-level certificate availability, and fulfillment reliability. Both are research-use-only materials, not therapeutics, and a returning buyer's job is to re-verify the paperwork rather than assume last year's supplier is still running the same program.

Why these two compounds keep appearing on the same order sheet

The two act on different receptors, which is the entire reason research groups study them side by side. CJC-1295 is an analog of growth hormone releasing hormone — specifically a modified fragment of the GRF (1-29) sequence, with substitutions that make it more resistant to enzymatic cleavage than native GHRH. It works, in the published literature, at the GHRH receptor on the anterior pituitary.

The "No DAC" designation matters more than most buyers realize. The DAC version carries a reactive linker that binds covalently to serum albumin, dramatically extending circulating half-life in preclinical models. Strip that moiety out and you have a short-acting GHRH analog — functionally much closer to what older literature calls modified GRF (1-29) or CJC-1295 without DAC. Researchers choosing the No DAC form are usually choosing it deliberately, because they want a short signaling window rather than a sustained one. That is a study-design decision, not a product upgrade, and it is why the two forms are not interchangeable on a catalog line.

Ipamorelin sits in a different class. It is a pentapeptide described in the literature as a ghrelin receptor (GHS-R1a) agonist, and the interest in it historically came from reports that it stimulated growth hormone release in preclinical models with comparatively little effect on other pituitary hormones. Research suggests that selectivity is what distinguishes it from earlier, less discriminating secretagogues. Because the two compounds engage separate receptor systems, investigators studying pituitary signaling frequently order both — not as a bundle, but because a well-designed experiment needs both arms.

For a wholesale buyer, the practical consequence is simple: these are two independent SKUs with independent synthesis, independent lots, and independent certificates. Treat them that way at receiving.

What actually varies from lot to lot

This is the part returning buyers underestimate. Two vials with the same label can differ in ways that matter analytically.

Both compounds are made by solid-phase peptide synthesis, then cleaved, precipitated, purified — usually by preparative reverse-phase HPLC — and lyophilized. Every one of those steps introduces variables. Truncated and deletion sequences, incompletely deprotected side chains, and oxidation products are the typical peptide-related impurities, and they are what an HPLC purity figure is actually measuring: the area percentage of the main peak relative to all detected peptide-related species at a given wavelength.

Here is the distinction that separates a sophisticated buyer from a casual one. HPLC purity is not the same as net peptide content. A lyophilized peptide also contains residual water and a counterion — commonly acetate, sometimes trifluoroacetate depending on how the purification and salt exchange were handled. A lot can be 99%-plus pure by HPLC and still contain a meaningful non-peptide mass fraction. If you have ever had two lots behave differently in the same protocol despite identical purity numbers on the label, salt form and water content are the first place to look.

Identity is the second variable. Purity tells you the main peak is homogeneous; it does not tell you the main peak is the sequence you ordered. Mass spectrometry — confirming that the observed molecular mass matches the theoretical mass for the sequence — is what closes that gap. A certificate that reports purity without identity confirmation is answering half the question.

The third variable is sterility and endotoxin status, which is a documentation question rather than a performance one for research materials, and one your own quality process should define before you buy.

How to read a certificate of analysis without taking it on faith

A COA is only evidence if it is traceable to the lot in your hand. Check four things.

Lot linkage. The batch or lot number on the certificate must match the number printed on the vial or its carton. A generic "typical analysis" document with no lot number is a marketing sheet, not a certificate. This is the single most common weak point in the market.

Method disclosure. The certificate should say how each result was produced — the analytical technique, and enough detail that a competent chemist could evaluate it. Purity by HPLC, identity by mass spectrometry, and separately reported water content, counterion content, and microbial or endotoxin panels are the categories you will commonly see referenced. Results with no stated method are unverifiable by definition.

Independence. Ask whether testing is in-house, third-party, or both, and whether the testing laboratory is named. Neither answer is automatically disqualifying — plenty of legitimate manufacturers run robust internal QC — but you should know which you are being shown.

Accessibility. Can you pull the certificate yourself, without asking anyone, before you commit to an order? Some operators charge for COAs, release them only after purchase, or send a PDF with the lot field blank. Those are all practices worth walking away from, and you do not need to name a competitor to recognize the pattern.

What to re-verify before you place a repeat order

Run this list every time, not once. Suppliers change contract manufacturers, change salt forms, and change testing arrangements without announcing it. A returning buyer who re-runs the checklist catches the drift; one who reorders from memory does not.

Storage, labeling, and inventory questions returning buyers ask

Lyophilized peptides are generally supplied as a dry powder precisely because the dry state is more stable than solution. For inventory purposes, that means your controllable variables are temperature, light, and moisture ingress on unopened vials, plus the discipline of first-in-first-out rotation against the lot dates you have on file. Follow whatever storage conditions the supplier states on the product documentation for that specific lot — general internet advice is not a substitute for the manufacturer's own stated conditions.

The operational mistake that costs resellers the most is record-keeping, not refrigeration. If you cannot match a vial on your shelf to a certificate in your files, that unit is functionally undocumented no matter how it was stored. Build receiving around three steps: record the lot number, download and archive the matching certificate that day, and reconcile quantity against the packing document before anything reaches a shelf. If a customer or an auditor later asks what you can prove about a specific unit, that archive is the answer.

Keep research-use-only labeling intact and consistent in every downstream context — your catalog copy, your invoices, your website. Anything that beyond in-vitro or preclinical research scope belongs with a licensed professional and your own counsel, not with a supplier.

The compliance questions that belong with your counsel

This section is informational and is not legal advice. Nothing here substitutes for a lawyer who knows your business and your jurisdiction.

The framework questions a reseller or clinic operator should be putting to counsel — rather than to a supplier or a forum — generally include: How does my state's regulatory structure treat the resale of research-use-only materials, and does my entity type or professional licensure change that answer? What labeling, record-retention, and customer-representation obligations apply to how I list and describe these compounds? Do my marketing claims stay within what the material actually is, or does my copy drift toward implying a use it is not sold for? What does my state board say about my scope of practice, if I hold a license at all?

Those are questions, deliberately. Regulatory treatment varies by state and by business model, guidance shifts, and a supplier who answers them for you with confident specifics is doing you a disservice. Verify your own position with your attorney and, where relevant, your state board — and get it in writing before you build a catalog on top of it.

What Real Peptides does differently

Real Peptides built its Wholesale Partner Program around removing the verification friction described above.

Every compound in the catalog, including CJC-1295 No DAC 10mg and Ipamorelin 10mg, is tested to 99%+ HPLC purity and run through a 7-panel batch testing process. Certificates of analysis are publicly verifiable — meaning a prospective partner can inspect the lab results directly, before ordering, without submitting a request or paying for the document. That is the point of publishing them: a buyer who can check the work does not have to trust a claim.

Fulfillment is US-based, with orders shipping in 5–7 days, which makes reorder points something a partner can actually plan around rather than estimate. And the Wholesale Partner Program runs on a 3-step application, so a qualified business finds out quickly whether the program fits.

Everything in the catalog is sold for research use only. Real Peptides does not supply semaglutide, tirzepatide, retatrutide, or melanotan-family GLP-1 or tanning compounds through the program, and does not pair compounds with injection supplies. If a supplier is offering you those things as a package, that tells you something about how they operate.

If you previously ordered these two compounds and you are rebuilding your sourcing around documentation you can verify rather than claims you have to accept, the Wholesale Partner Program application at realpeptides.co is where a qualified business starts — bring your entity details and the volume you actually expect to move.

Researchers working adjacent pathways often review the broader growth factor and tissue signaling research collection alongside Tesamorelin 10mg, another GHRH analog, and the popular peptides range for catalog planning.